Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Skin Epithelial Neoplasm — Research · CancerIndex

Cancers
Neoplasm
Neoplasm by Morphology
Epithelial Neoplasm
Skin Epithelial Neoplasm

Cancer Family

Skin Epithelial Neoplasm

CI-CAN-00000350Explore in graph →

Non-malignant138 active trials2 approved drugs4 evidence items

NCIt: C7342

Overview
Statistics
Survival
Genomics5
Variants & evidence4
Drugs4
Trials451
Research
Rankings
Sources & provenance

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Trials tab
Methodology: publication counts

Literature

Linked publications (9)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedProvenance

Source: PubMed (NLM)
Dataset: PubMed E-utilities
Retrieved: Sep 8, 2026
Layer: normalized (units and labels harmonized; values unchanged)

PublishedShowing 1–9 of 9 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

BTK inhibitors are associated with a lower risk of myeloid neoplasms and non-melanoma skin cancer compared with chemoimmunotherapy in chronic lymphocytic leukemia: a propensity score-matched analysis.
Pratik Shah, Adit Singhal, Yu-Cheng Chang et al. · Leukemia · Aug 10, 2026 · PMID 42575952 · candidate dictionary pubmed
Mutational landscape of aggressive cutaneous squamous cell carcinoma.
· Clin Cancer Res · 2014 · PMID 25303977 · validated cbioportal_study pubmed
Epidermal Growth Factor Receptor P753S Mutation in Cutaneous Squamous Cell Carcinoma Responsive to Cetuximab-Based Therapy.
· J Clin Oncol · 2016 · PMID 24934779 · validated civic_curation pubmed
Metastatic Extramammary Paget's Disease of Scrotum Responds Completely to Single Agent Trastuzumab in a Hemodialysis Patient: Case Report, Molecular Profiling and Brief Review of the Literature.
· Case Rep Oncol Med · 2015 · PMID 25692060 · validated civic_curation pubmed
RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors.
· N Engl J Med · 2012 · PMID 22256804 · validated civic_curation pubmed
Bonilla et al. Nat Genet 2016
· 2016 · PMID 26950094 · validated cbioportal_study pubmed
Li et al. Clin Cancer Res 2015
· 2015 · PMID 25589618 · validated cbioportal_study

Showing 1–9 of 9 publications

Thind, Amarinder Singh et al. Front Oncol 2022

· 2022 · PMID 35982973 · validated cbioportal_study pubmed

Chang et al. NPJ Genom Med 2021

· 2021 · PMID 34272401 · validated cbioportal_study pubmed